Market News AIOpen the app

PLX stock news · Protalix BioTherapeutics, Inc.

Stories about Protalix BioTherapeutics, Inc. (PLX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for PLX

Follow Protalix BioTherapeutics, Inc. (PLX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for PLX
Free on the App Store and Google Play, or on the web.
  1. Nov 4, 2026, 2:13 AM ET · Market

    Protalix BioTherapeutics will share its third quarter 2026 sales and profit details on November 10, 2026.

    Neutral

    PLX scheduled its third-quarter 2026 results and a company update for November 10. No results were shared, so this notice does not change its outlook.

  2. Aug 12, 2026, 7:31 AM ET · Market

    Protalix BioTherapeutics, Inc. discloses operational outcomes and financial status (PLX).

    Neutral

    Protalix BioTherapeutics has released a Form 8-K that outlines its operational results and financial condition, which is crucial for stakeholders to assess the company's performance and future prospects. This filing is expected to influence investor sentiment positively.